These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9526572)

  • 1. Design, synthesis, and evaluation of the multidrug resistance-reversing activity of D-glucose mimetics of hapalosin.
    Dinh TQ; Smith CD; Du X; Armstrong RW
    J Med Chem; 1998 Mar; 41(6):981-7. PubMed ID: 9526572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of hapalosin and analogs as MDR-reversing agents.
    O'Connell CE; Salvato KA; Meng Z; Littlefield BA; Schwartz CE
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1541-6. PubMed ID: 10386932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical total synthesis of hapalosin, a 12-membered cyclic depsipeptide with multidrug resistance-reversing activity, by employing improved segment coupling and macrolactonization.
    Palomo C; Oiarbide M; García JM; González A; Pazos R; Odriozola JM; Bañuelos P; Tello M; Linden A
    J Org Chem; 2004 Jun; 69(12):4126-34. PubMed ID: 15176838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
    Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
    Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activities of hapalosin derivatives with modification at the C12 position.
    Kashihara N; To-e S; Nakamura K; Umezawa K; Yamamura S; Nishiyama S
    Bioorg Med Chem Lett; 2000 Jan; 10(2):101-3. PubMed ID: 10673089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance-modifying components in human plasma with potential clinical significance.
    Mülder HS; Pinedo HM; Timmer AT; Rao BR; Lankelma J
    J Exp Ther Oncol; 1996 Jan; 1(1):13-22. PubMed ID: 9414384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis and conformational studies of hapalosin, N-desmethylhapalosin and 8-deoxyhapalosin.
    Wagner B; Gonzalez GI; Tran Hun Dau ME; Zhu J
    Bioorg Med Chem; 1999 May; 7(5):737-47. PubMed ID: 10400327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
    Kim HS; Min YD; Choi CH
    Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of multidrug resistance-related ATP-binding-cassette transporter proteins on the cytoskeletal activity of cytochalasins.
    Berger W; Micksche M; Elbling L
    Exp Cell Res; 1997 Dec; 237(2):307-17. PubMed ID: 9434626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
    Coburger C; Wollmann J; Krug M; Baumert C; Seifert M; Molnár J; Lage H; Hilgeroth A
    Bioorg Med Chem; 2010 Jul; 18(14):4983-90. PubMed ID: 20598550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
    Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
    Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
    Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
    Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thieno[2,3-b]pyridines--a new class of multidrug resistance (MDR) modulators.
    Krauze A; Grinberga S; Krasnova L; Adlere I; Sokolova E; Domracheva I; Shestakova I; Andzans Z; Duburs G
    Bioorg Med Chem; 2014 Nov; 22(21):5860-70. PubMed ID: 25311564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
    Wang F; Jiang X; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
    van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
    Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity-oriented asymmetric synthesis of hapalosin: construction of three small C9/C4/C3-modified hapalosin analogue libraries.
    Dai CF; Cheng F; Xu HC; Ruan YP; Huang PQ
    J Comb Chem; 2007; 9(3):386-94. PubMed ID: 17358084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.